However, miR-181d was also found to be upregulated in CRC and involved in the post-transcriptional regulation of c-MYC by targeting FBXL3 and CRY2, as well as in the regulation of KRAS expression [82–85]. The gene discussed is KRAS; the disease is colorectal carcinoma.